Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panel
The treatment, known as molnupiravir, could be authorized in the United States within days, and available within weeks, if the F.D.A. follows the committee’s recommendation.
Full Article
Merck’s Covid Treatment Pill Wins Blessing of F.D.A. Panel
NYTimes.com
0 shares
3 views
You might like
Related news coverage
U.S. Adds Merck Pill As 2nd Easy-To-Use Drug Against COVID-19
Newsy
Watch VideoU.S. health regulators on Thursday authorized the second pill against COVID-19, providing another easy-to-use medication..
